GODAVARI DRUGS LTD.
BSE: 530317
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 33.16+49.5% | 22.18-16.8% | 26.65+11.9% | 23.81-6.6% | 25.50-13.7% | 29.55+13.3% | 26.09 |
| Other Income | 0.14+766.3% | 0.02-97.4% | 0.64+5108.2% | 0.01-88.4% | 0.11+7.2% | 0.10+988.9% | 0.01 |
| Total Income | 33.30+50.0% | 22.20-18.6% | 27.28+14.5% | 23.82-7.0% | 25.61-13.6% | 29.65+13.6% | 26.10 |
| EXPENSES | |||||||
| Expenditure | 31.79+48.3% | 21.43-18.1% | 26.16+16.2% | 22.52-6.8% | 24.17-15.9% | 28.73+15.6% | 24.84 |
| Tax | 0.33+23.7% | 0.26+119.1% | 0.12-53.9% | 0.26-52.1% | 0.55+255.0% | 0.15-6.1% | 0.16 |
| PROFIT | |||||||
| PBT | 1.62+58.3% | 1.02-8.9% | 1.12-13.9% | 1.30-9.5% | 1.44+56.3% | 0.92-26.4% | 1.25 |
| Net Profit | 1.29+70.4% | 0.76-24.3% | 1.00-3.8% | 1.04+16.5% | 0.89+16.4% | 0.77-29.6% | 1.09 |
| KEY METRICS | |||||||
| OPM % | 9.18%-3.12pp | 12.30%+4.80pp | 7.50%-4.67pp | 12.17%-0.04pp | 12.21%+15.36pp | -3.15%-1.54pp | -1.61% |
| NPM % | 3.88%+0.47pp | 3.41%-0.26pp | 3.67%-0.70pp | 4.37%+0.88pp | 3.49%+0.90pp | 2.59%-1.58pp | 4.17% |
| EPS | 1.71+69.3% | 1.01-24.1% | 1.33-3.6% | 1.38+16.0% | 1.19+16.7% | 1.02-29.7% | 1.45 |
Corporate Events
Board MeetingGODAVARI
202624Aug
Board Meeting
A meeting of the Board of Directors of the Company is schedu…
BSE Filing ↗ Board MeetingGODAVARI
202627May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingGODAVARI
202414Aug
Board Meeting
Consider and approve the un-audited Financial Results/Statem…
BSE Filing ↗ Board MeetingGODAVARI
202430May
Board Meeting
Consider and approve audited financial results/statements
BSE Filing ↗